Nasex
Brand Names
Aldex G, Aquatab D, Crantex, D-Phen 1000, D-Tab, Deconex, Deconsal II, Deconsal Pediatric, Despec, Donatussin Drops, Duomax, Duraphen 1000, Duraphen II, Duratuss, Dynex LA, ExeTuss, Extendryl G, Fenesin PE IR, Genexa LA, Gentex LA, Gilphex TR, Guaiphen-D 1200, Guaiphen-D 600, Guaiphen-PD, Guiadex PD, Guiatex PE, J-Max, Liquibid D-R, Liquibid-D, Liquibid-PD, Lusonex, Maxiphen, Medent-PE, MontePhen, Mucinex Children's Cold, Mucus Relief Sinus, Mydex, Nariz, Nasex, Nescon-PD, Nexphen PD, Norel EX, PE-Guai, Pendex, Prolex D, Refenesen PE, Reluri, Rescon-GG, Respa-PE, Robitussin Head & Chest Congestion, Simuc, Simuc-GP, Sina-12X, Sinupan, SINUvent PE, Sitrex PD, Sudafed PE Non-Drying Sinus, Sudex, Triaminic Chest & Nasal Congestion, Visonex, Wellbid-D, Xedec, Xedec II, Xpect-PE, Zotex GPXWhat is Nasex
Nasex is a medication that is aimed to give a temporary relief of nasal congestion caused by colds, flu or hayfever.
Side effects of Nasex
Nasex may cause the following side effects:
- joint pain
- asthma
- bronchitis
- chest pain
- conjunctivitis
- diarrhea
- upset stomach or indigestion
- earaches
- muscle pain
- nausea
Indication
Nasex is effective in the treatment of nasal symptoms such as congestion, sneezing and runny nose caused by seasonal or year-round allergies. This medication is also aimed for treating growths in the nose (nasal polyps) in adults. It contains the combination of guaifenesin and phenylephrine which is used to treat stuffy nose and sinus congestion and to decrease chest congestion caused by the common cold or flu.
Precautions
You should discuss the usage of this medication with your doctor if you have one of the following conditions:
- heart disease or high blood pressure
- diabetes
- circulation problems
- glaucoma
- overactive thyroid
- enlarged prostate or problems with urination
Dosage forms
The recommended dose for adults and children over 6 years: 1-2 sprays in each nostril - may be repeated up to 2-3 times a day. If symptoms persist longer than 5 days consult your doctor.
